Skip to main content
. 2023 Aug 3;2(4):100161. doi: 10.1016/j.jacig.2023.100161

Table V.

Active asthma duration (d, mean ± SD) in asthmatic children with RSV bronchiolitis hospitalization history with and without palivizumab exposure

Group Palivizumab unexposed Palivizumab exposed P value
All ages (n = 70) 999 ± 998 595 ± 651 .046
3 y old (n = 59) 700 ± 395 330 ± 334 <.001
6 y old (n = 68) 899 ± 731 553 ± 575 .032
9 y old (n = 70) 965 ± 898 578 ± 616 .037
12 y old (n = 70) 999 ± 999 595 ± 651 .046

P < .05.